Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand

• المؤلفون الرئيسيون: Lojanapiwat B., Pripatnanont C., Choonhaklai V., Soontornpun S., Sriplakich S., Leewansangtong S., Santi-ngamkun A., Opanuraks J., Kongcharoensombat W., Na-Songkla B., Raksakul W., Predanon C.
• التنسيق: دورية
• منشور في: 2017
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85012939668&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/40714

© 2017 Treatment options for castration-resistant prostate cancer (CRPC) are available, but clear instructions for the selection of appropriate treatment are lacking. A meeting of urology experts based in Thailand was convened with the following objectives: (1) to reach a consensus and share real-li...